Firmaet fremlagde også videnskabelige beviser for, at den dosis alendronat, som ADROVANCE indeholdt, svarede til den dosis, der var nødvendig for at forhindre tab af knoglemasse.
The company also presented evidence that the dose of alendronate included in ADROVANCE was the same as the dose needed to prevent bone loss.